Patient Blood Management Market Research Report - Forecast till 2027

Patient Blood Management Market Research Report: By Product (Instruments, Accessories, Reagents and Kits, Software), By Component (Whole Blood, Plasma) and By End-User (Blood Banks, Hospitals, Diagnostic Clinics and & Pathology Labs)-Forecast to 2027

ID: MRFR/HC/7326-HCR | February 2021 | Region: Global | 112 pages

Patient Blood Management Market Forecast

Patient Blood Management Market is expected to cross USD 15,848 Million by 2027 at a CAGR of 7.56% during the forecast period of 2019 to 2027.

Patient Blood Management Market Synopsis

Patient Blood Management (PBM) is a standard plan for the management of a patient’s blood to minimize the blood loss during the surgical techniques, optimize tolerance of anemia, and optimize patients’ blood. PBM is a standard care plan performed by medical practitioners for patients who have a high risk of blood loss during surgical intervention.

The high number of blood donations and rising prevalence of target diseases will support the growth of the market. According to the World Health Organization (WHO), about 108 million blood donations were collected globally every year.

Market Influencer

Rising prevalence of target diseases and the increasing number of blood donations are likely to impact the growth of the patient blood management industry positively.

Patient Blood Management Market Drivers

  • The rising prevalence of target diseases drives the growth of the patient blood management market.

  • he forecast period. According to the National Health Commission (NHC), the number of voluntary blood donations increasing from 328,000 in 1998 to 14.59 million in 2017.

  • Increasing demand for donated blood across the globe is expected to drive patient blood management market growth

Patient Blood Management Market Restraints

  • The high cost of automated systems is likely to hamper the growth of the patient blood management market during the forecast period

Patient Blood Management Market Segmentation

By Product

  • Instruments: Instruments are majorly used during the blood management process. The instruments segment includes blood processing devices, blood transfusion devices, blood culture screening devices, diagnostic & testing instruments, and blood storage devices. This segment holds the most significant share in the product segment. Fresenius Health Care Group offers blood processing devices including CompoGuard, CompoDock, CompoLab, and among others

  • Accessories: Accessories are used to support the process blood management operates during the blood transfusion, blood testing & diagnostic process.

  • Reagents and Kits: Reagents & kits are composed of chemical compounds such as solvents and nutrients that are used for promoting the growth of different types of blood cells. It used for the major purpose of testing & diagnostic.

  • Software: Blood management software used to secure & safety supply of blood in the hospitals. The company, such as Mediware Information Systems (US), offers blood transfusion software in the market.

By Component

  • Whole Blood: The whole blood includes white & red blood cells and platelets. It can store or used for transfusion after blood loss. This segment holds the most significant share in the component segment due to the large preference for the blood transfusion.

  • Plasma: Plasma is the largest element of blood; it takes about 55% of its overall blood content. Plasma transfusion used in the treatment of critically ill patients.

By End-User

  • Blood Banks: The blood collected from the donor is a further process and stored in the blood banks.

  • Hospitals: Patient blood management plays a major role in hospitals. The increasing numbers of surgical procedures will support the growth of the patient blood management market.

  • Diagnostic Clinics and & Pathology Labs: Recently, many diagnostic centers are providing diagnostic tests for blood-related diseases. More than 200,000 diagnostics laboratories provide various diagnostic tests in the US. This high number of labs support the growth of the market

By Region

  • Americas: The Americas held the largest regional market share in 2018. This is owing to the high number of surgical procedures and the rising incidence of cancer. For instance, in 2016, according to the Healthcare Cost and Utilization Project (HCUP) report, an estimated about 13.6 million surgical procedures were performed in ambulatory care centers in the US. Moreover, the presence of a large number of hospitals in the US is likely to support market growth. The US has over 7,200 active hospitals and a well-established healthcare sector.

  • Europe: The increasing number of blood donations, rising numbers of road traffic accidents, and the well-developed healthcare system drive the market in the region. According to the Federal Statistical Office of Germany, the number of people injured in road accidents grew by 1.8% from November 2018 to November 2019.

  • Asia-Pacific: The Asia-Pacific is the fastest-growing regional market for the patient blood management market. It has the world’s largest population and rapidly developing the healthcare sector.

  • Middle East & Africa: It is estimated to account for the least share of the global market due to the limited development of healthcare facilities.

Patient Blood Management Market Key Players

  • Biomérieux SA

  • Bio-Rad Laboratories, Inc.

  • Fresenius Se & Co. KGaA

  • Braun Melsungen AG

  • Abbott Laboratories

  • Danaher Corporation

  • Hitachi, Ltd.

  • Terumo Corporation

  • Grifols, S.A

  • Immucor, Inc.

  • Others

Report Scope:
Report Attribute/Metric Details
  Market Size   2027: USD 15,848 Million
  CAGR   7.56% (2019-2027)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product, Component and End-User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Biomérieux SA, Bio-Rad Laboratories, Inc., Fresenius Se & Co. KGaA, B. Braun Melsungen AG, Abbott Laboratories, Danaher Corporation, Hitachi, Ltd., Terumo Corporation, Grifols, S.A, Immucor, Inc., and others.
  Key Market Opportunities   Rising Prevalence of Target Diseases and the increasing number of blood donations are likely to impact the growth of the Patient Blood Management Industry Positively
  Key Market Drivers

  • The Rising Prevalence of Target Diseases Drives the growth of the market.
  • Increased Blood Donators will support the growth of the market during the forecast period.
  • Increasing Demand for Donated Blood across the globe is expected to drive Market Growth

  • Frequently Asked Questions (FAQ) :

    Global patient blood management market is estimated hold a market value of USD 15,848 million by the end of 2025.

    Global patient blood management market is anticipated to thrive at a CAGR of 6.48% by the end of 2025.

    The APAC region is estimated to be the fastest growing regional market.

    The global patient blood management market can be segmented on the basis of component, product, end-user, and region.

    Hitachi, Ltd., Braun Melsungen AG, Bio-Rad Laboratories, Inc., Grifols, S.A are some of the eminent players of the global patient blood management market.

    This table of content is tentative and subject to change as the research progresses.

    Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.